The<unk>  prevention of<unk>  syndrome is anticoagulation with low-dose aspirin or warfarin in patients with risk factors for arterial and venous thrombosis, daily low dose of aspirin for<unk>  thrombosis prevention in asymptomatic individuals with persistent<unk>  antibodies, minimizing the contribution of reversible risk factors for recurrent thrombosis and use of statins in patients with hyperlipidemia.
Antiphospholipid syndrome primary prevention
Antiphospholipid syndrome secondary prevention
Antiphospholipid syndrome medical therapy
Thrombophilia secondary prevention
Thrombophilia primary prevention
Glanzmann's thrombasthenia medical therapy
Heparin-induced thrombocytopenia primary prevention
Heparin-induced thrombocytopenia future or investigational therapies